Belhaven Biopharma

BiotechRaleighGrowth

belhavenbio.com

Developing Nasdepi, a dry powder nasal epinephrine product for severe allergic reactions.

At a glance

Founded: 2020
HQ: Raleigh
Sector: Biotech
Stage: Growth
Total raised: $32.3M

Funding sources

Sources attached to recorded funding rounds.

sec.gov

See the full company record.

Founders, funding history and recent signals. Free accounts open immediately.

Where the team studied

Filter the directory by school

University of North Carolina at Chapel Hill

Dave NealAlumundergraduate and law degreesSource
Dave NealFacultyProfessor of the Practice of Entrepreneurship, Kenan-Flagler Business SchoolSource

Each line was checked against a primary source. Founder education is recorded for part of the directory, so a name missing here is a gap in what has been checked, not a statement that they studied somewhere else. Tell me what is missing.

We don’t have a confirmed role to show at Belhaven Biopharma.

If you want to work here anyway, tell us what you are after and Adam will pass it to the Belhaven Biopharma team when there is a real fit.

Listed roles

All Triangle roles

Checking listed roles…